天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

ChemicalBook
Chinese English Germany Korean

bioleaper 企業(yè)の連絡(luò)先情報

名前:bioleaper
電話番號:-
電子メール:guojing@bioleaper.com
國籍:China
ウェブサイト:www.bioleaper.com/
商品の合計數(shù):5616
46 47 48 49 50 51 52 53 54 55 56 57

製品カタログ

Anti-IL-2Ra / CD25 Reference Antibody (basiliximab)
Anti-IL-2Ra / CD25 Reference Antibody (camidanlumAb)
Anti-IL-2Ra / CD25 Reference Antibody (daclizumab)
Anti-IL-2Rb / CD122 Reference Antibody (Singapore ASTR patent anti-IL-2R beta / IL-2R gamma )
Anti-IL-31Ra Reference Antibody (nemolizumab)
Anti-IL-33 Reference Antibody (etokimab)
Anti-IL-33 Reference Antibody (itepekimab)
Anti-IL-33 Reference Antibody (torudokimab)
Anti-IL-33 Reference Antibody (tozorakimab)
Anti-IL-3Ra / CD123 Reference Antibody (SNG-CD123A)
Anti-IL-3Ra / CD123 Reference Antibody (talacotuzumab)
Anti-IL-4 Reference Antibody (pascolizumab)
Anti-IL-4Ra / CD124 Reference Antibody (dupilumab)
Anti-IL-4Ra / CD124 Reference Antibody (MEDI2045)
Anti-IL-5 Reference Antibody (Abgenix anti-IL-5)
Anti-IL-5 Reference Antibody (depemokimab)
Anti-IL-5 Reference Antibody (mepolizumab)
Anti-IL-5Ra/ CD125 Reference Antibody (benralizumab)
Anti-IL-6 / IFNb2 Reference Antibody (Chugai SK2)
Anti-IL-6 / IFNb2 Reference Antibody (clazakizumab)
Anti-IL-6 / IFNb2 Reference Antibody (CSTRI patent anti-IL-6)
Anti-IL-6 / IFNb2 Reference Antibody (elsilimomab)
Anti-IL-6 / IFNb2 Reference Antibody (Medarex patent anti-IL-6)
Anti-IL-6 / IFNb2 Reference Antibody (MEDI 5117)
Anti-IL-13 Reference Antibody (M1295)
Anti-IL-13 Reference Antibody (tralokinumab)
Anti-IL-13Ra1 / CD213a1 Reference Antibody (MK-6105)
Anti-IL-13Ra2 / CD213a2 Reference Antibody (Wake Forest U. patent anti-IL-13RA2)
Anti-IL-15 Reference Antibody (DISC0280)
Anti-IL-15 Reference Antibody (ordesekimab)
Anti-IL-17c Reference Antibody (MOR106)
Anti-IL-17Ra / CD217 Reference Antibody (brodalumab)
Anti-IL-18 Reference Antibody (ABT-325)
Anti-IL-18 Reference Antibody (GSK 1070806)
Anti-IL-1a Reference Antibody (bermekimab)
Anti-IL-1b Reference Antibody (canakinumab)
Anti-IL-1b Reference Antibody (CDP484)
Anti-IL-1b Reference Antibody (gevokizumab)
Anti-IL-1R1 / CD121a Reference Antibody (AMG 108)
Anti-IL-1RAP / IL-1R3 Reference Antibody (nidanilimab)
Anti-IL-1RL1 / ST2 / IL-33R Reference Antibody (astegolimab)
Anti-IL-1RL1 / ST2 / IL-33R Reference Antibody (melrilimab)
Anti-IL-1RL2 / IL-36R Reference Antibody (imsidolimab)
Anti-IL-1RL2 / IL-36R Reference Antibody (spesolimab)
Anti-IL-20 Reference Antibody (Cheng Kung U. patent anti-IL-20)
Anti-IL-20 Reference Antibody (fletikumab)
Anti-IL-20Ra Reference Antibody (Cheng Kung U. patent anti-IL-20R1)
Anti-IL-21 Reference Antibody (avizakimab)
Anti-IL-21 Reference Antibody (Lilly patent anti-IL-21)
Anti-IL-22 Reference Antibody (fezakinumab)
Anti-IL-22Ra Reference Antibody (ARGX-112)
Anti-IL-23 Reference Antibody (brazikumab)
Anti-IL-23 Reference Antibody (guselkumab)
Anti-IL-23 Reference Antibody (LY2525623)
Anti-IL-23 Reference Antibody (mirikizumab)
Anti-IL-23a Reference Antibody (risankizumab)
Anti-IL-23a Reference Antibody (tildrakizumab)
Anti-IL-25 Reference Antibody (Centocor patent anti-IL-25)
Anti-IL-6 / IFNb2 Reference Antibody (Merck patent anti-IL-6)
Anti-IL-6 / IFNb2 Reference Antibody (olokizumab)
Anti-IL-6 / IFNb2 Reference Antibody (siltuximab)
Anti-IL-6 / IFNb2 Reference Antibody (sirukumab)
Anti-IL-6 / IFNb2 Reference Antibody (ziltivekimab)
Anti-IL-6Ra / CD126 Reference Antibody (APX007)
Anti-IL-6Ra / CD126 Reference Antibody (levilimab)
Anti-IL-6Ra / CD126 Reference Antibody (sapelizumab)
Anti-IL-6Ra / CD126 Reference Antibody (sarilumab)
Anti-IL-6Ra / CD126 Reference Antibody (tocilizumab)
Anti-IL-6Ra / CD126 Reference Antibody (vobarilizumab)
Anti-IL-7Ra / CD127 Reference Antibody (lusvertikimab)
Anti-IL-7Ra / CD127 Reference Antibody (PF-06342674)
Anti-IL-9 Reference Antibody (enokizumab)
Anti-ILDR2 Reference Antibody (bapotulimab)
Anti-INHBA / Activin A Reference Antibody (garetosmab)
Anti-INHBB / Activin B Reference Antibody (Oxford Brookes U. patent anti-Activin Beta-B)
Anti-Integrin a11 / ITAG11 Reference Antibody (Scripps patent anti-CD11a)
Anti-Integrin a2b1 (ITGA2 & ITGB1) Reference Antibody (vatelizumab)
Anti-Integrin a2b3 (ITGA2 & ITGB3) Reference Antibody (tadocizumab)
Anti-Integrin a4b7 (ITGA4 & ITGB7) Reference Antibody (abrilumab)
Anti-Integrin a4b7 (ITGA4 & ITGB7) Reference Antibody (etrolizumab)
Anti-Integrin a4b7 (ITGA4 & ITGB7) Reference Antibody (vedolizumab)
Anti-Integrin a5b1 (ITGA5 & ITGB1) Reference Antibody (BMS patent anti-Integrin α5β1)
Anti-Integrin a5b1 (ITGA5 & ITGB1) Reference Antibody (volociximab)
Anti-Integrin aL / ITGAL / CD11a Reference Antibody (efalizumab)
Anti-Integrin aV / ITGAV / CD51 Reference Antibody (abituzumab)
Anti-Integrin aV / ITGAV / CD51 Reference Antibody (intetumumab)
Anti-Integrin aVb3 (ITGAV & ITGB3) Reference Antibody (etaracizumab)
Anti-Integrin aVb6 (ITGAV & ITGB6) Reference Antibody (STX-100)
Anti-Integrin b1 / ITGB1 / CD29 Reference Antibody (OS2966)
Anti-Integrin b2 / ITGB2 / CD18 Reference Antibody (erlizumab)
Anti-Integrin b7 / ITGB7 Reference Antibody (Genentech patent anti-Integrin β7)
Anti-KAAG1 Reference Antibody (ADCT-901)
Anti-KID3 Reference Antibody (Macrogenics patent anti-KID3)
Anti-KIR Reference Antibody (lirilumab)
Anti-KIR2DL1 / CD158a Reference Antibody (Innate patent anti-KIR2DL)
Anti-KIR3DL2 / CD158k Reference Antibody (lacutamab)
Anti-KLK2 / Kallikrein 2 Reference Antibody (JNJ-69086420)
Anti-KLK5 / Kallikrein 5 Reference Antibody (Genentech patent anti-KLK5)
Anti-Klotho Beta Reference Antibody (NGM313)
Anti-Klotho Beta Reference Antibody (RG7992)
46 47 48 49 50 51 52 53 54 55 56 57
Copyright 2017 ? ChemicalBook. All rights reserved